TAMI (IMI) Central R&D; Inst.
Font Size:
Site Colors:
Accesskey
S - Skip navigation
1 - Home page
4 - Search
Accessibility Statement

News

FDA INSPECTION Dec 2022

20/02/2023
Tami-imi successfully completed an FDA inspection of our QC Pharma lab cGMP operations.

IMI's primary

12/12/2017
IMI's primary goal is to expand the business of the ICL Group by improving existing chemical production processes for "me-too" products and developing new, proprietary chemical compounds having a commercial advantage.

VISIT US AT ISRANALYTICA 2023 BOOTH 12

17/01/2023

SEP 2018 – MOH YAKAR APPROVAL FOR CANNABIS ANALYSES

1/09/2018

We offer research

12/12/2017
We offer research, analytical, testing and consultancy services and can manufacture to your requirements in quantities from less than a kilogram to tens of tons.